Aurora Sheboygan Prices – Ado-Trastuzumab Emtansine 160 Milligrams Intravenous Solution at $263.67

Ado-Trastuzumab Emtansine is a specialized targeted therapy used primarily for patients with HER2-positive breast cancer. At Aurora Medical Center Sheboygan County, a 160-milligram intravenous dose is priced at $263.67. This fee typically covers the drug itself and the preparation for its intravenous administration, but may not include additional services such as clinic visit charges, infusion fees, or supportive medications. Patients should request an itemized estimate from the facility to clarify all included and potential additional costs before beginning treatment.

Cost Breakdown

• Drug Cost (160 mg Ado-Trastuzumab Emtansine): $263.67
• Possible Additional Costs:
  • Infusion services/administration fees
  • Pre-medications or supportive drugs
  • Lab work and monitoring during treatment
  • Physician or specialist consultation fees
  • Follow-up visits and imaging

Insurance & Payment Advice

• Contact your insurance provider to verify coverage for Ado-Trastuzumab Emtansine and related infusion services.
• Ask the hospital for a detailed, itemized estimate before each cycle of treatment.
• Inquire about financial assistance programs or drug manufacturer support if you have high out-of-pocket costs.
• Check if pre-authorization is required to avoid coverage delays or denials.

Associated Costs & Recovery Considerations

• Some patients may require lab tests or imaging before each infusion to monitor for side effects.
• Common side effects (e.g., fatigue, nausea, low platelet counts) may require additional medications or clinic visits.
• Plan for possible time off work or transportation support on infusion days.

Frequently Asked Questions

• What is Ado-Trastuzumab Emtansine used for?
  This medication is used for treating HER2-positive breast cancer, often after prior therapies have been tried.
• How is Ado-Trastuzumab Emtansine administered?
  It is given as an intravenous infusion directly into the bloodstream, typically in a clinical setting.
• Does the $263.67 cost include the entire treatment session?
  No, this fee covers the drug itself for a single 160 mg dose; additional costs for infusion, labs, or clinic fees may apply.
• Will my insurance cover this medication?
  Coverage varies by plan. Contact your insurer for details and confirm if pre-authorization is needed.
• Are there financial assistance programs available?
  Many hospitals and drug manufacturers offer financial assistance for eligible patients. Ask your care team or social worker for details.
• What are common side effects I should prepare for?
  Side effects may include fatigue, nausea, low blood counts, and liver enzyme changes. Discuss management strategies with your care team.
• How often will I need to receive this treatment?
  The frequency is determined by your oncologist, often every three weeks, but individual schedules may vary.
• What should I do if I experience severe side effects?
  Contact your healthcare provider immediately if you have severe or unexpected reactions during or after treatment.
• Can I receive this treatment at a different facility?
  You may be able to, but confirm with your insurance and discuss with your oncologist to coordinate care and coverage.
• How can I get an itemized cost estimate?
  Request a detailed, itemized estimate from the hospital’s billing department before starting therapy.

Aurora Medical Center Sheboygan County, located at 3400 Union Ave, Sheboygan, WI, offers a range of medical services, including the administration of Ado-Trastuzumab Emtansine, a targeted cancer therapy used primarily for treating HER2-positive breast cancer. This intravenous solution, priced at $263.67 for a 160-milligram dose, is designed to deliver chemotherapy directly to cancer cells, minimizing damage to healthy cells and potentially reducing side effects. The cost reflects the hospital’s pricing for this specific dosage, which is part of a comprehensive treatment plan tailored to the patient’s medical needs.

What is Ado-Trastuzumab Emtansine? – Ado-Trastuzumab Emtansine is a targeted cancer therapy used to treat HER2-positive breast cancer by delivering chemotherapy directly to cancer cells.

How is Ado-Trastuzumab Emtansine administered? – It is administered intravenously, meaning it is delivered directly into the bloodstream through an IV.

What is the cost of Ado-Trastuzumab Emtansine at Aurora Medical Center Sheboygan County? – The cost for a 160-milligram dose is $263.67, according to the hospital’s pricing.

Why is Ado-Trastuzumab Emtansine used in cancer treatment? – It is used because it targets cancer cells specifically, which can reduce side effects and improve treatment efficacy.

Who is eligible for Ado-Trastuzumab Emtansine treatment? – Patients with HER2-positive breast cancer may be eligible, but eligibility is determined by a healthcare provider based on individual medical conditions.

Are there any side effects associated with Ado-Trastuzumab Emtansine? – Yes, like all medications, it can have side effects, which should be discussed with a healthcare provider.

How often is Ado-Trastuzumab Emtansine administered? – The frequency of administration depends on the patient’s treatment plan, which is determined by their healthcare provider.

Is Ado-Trastuzumab Emtansine covered by insurance? – Coverage varies by insurance plan, so patients should consult with their insurance provider to determine coverage specifics.